| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |